LBA35 - TROPHIMMUN, a 2 cohort phase II trial of the anti-PD-L1 monoclonal antibody avelumab in chemo-resistant gestational trophoblastic neoplasia (GTN) patients: Preliminary outcomes in cohort A

B.M You,P.A Bolze,J.-P Lotz,J Massardier,L Gladieff,T Hajri,D Maucort-Boulch,S Bin,A Roux,P Rousset,G Freyer,F Golfier

doi:10.1093/annonc/mdy424.042

LBA35 - TROPHIMMUN, a 2 cohort phase II trial of the anti-PD-L1 monoclonal antibody avelumab in chemo-resistant gestational trophoblastic neoplasia (GTN) patients: Preliminary outcomes in cohort A

B.M You, P.A Bolze + Show 10 more

Open Access

https://doi.org/10.1093/annonc/mdy424.042

Copy DOI

Journal: Annals of Oncology	Publication Date: Oct 1, 2018
Citations: 1	License type: publisher-specific-oa

Affiliation: Hospices Civils de Lyon, University Cancer Institute Toulouse Oncopole, Hôpital Lyon Sud

#Chemo-resistant Gestational Trophoblastic Neoplasia #Gestational Trophoblastic Neoplasia + Show 5 more

Abstract
Full-Text PDF
Similar Papers

Abstract

LBA35 - TROPHIMMUN, a 2 cohort phase II trial of the anti-PD-L1 monoclonal antibody avelumab in chemo-resistant gestational trophoblastic neoplasia (GTN) patients: Preliminary outcomes in cohort A

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.